Shrewsbury, MA, United States of America

Chris H Senanayaka


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chris H Senanayaka: A Pioneer in Pharmaceutical Patents

Introduction: Chris H Senanayaka, a distinguished inventor based in Shrewsbury, MA, has made significant contributions to the field of pharmaceuticals through his innovative processes. With a remarkable patent to his name, he has exemplified the spirit of invention and the pursuit of excellence in research and development.

Latest Patents: Chris Senanayaka holds a patent for a process related to Formoterol tartrate, specifically a method for the preparation of a highly pure salt of R,R-formoterol L-tartrate. This innovative process not only provides the most thermodynamically stable polymorph through the recrystallization of a novel polymorph but also highlights the importance of purity in pharmaceutical applications.

Career Highlights: Throughout his career, Chris has been associated with Sepracor, Inc., where he has leveraged his expertise to advance pharmaceutical research and create new solutions. His focus on improving drug formulation and stability has made a notable impact in his field.

Collaborations: Chris has had the opportunity to collaborate with notable coworkers such as Gerald J Tanoury and Donald W Kessler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, essential for driving progress in research initiatives.

Conclusion: Chris H Senanayaka is not only an inventor but also a key contributor to the pharmaceutical industry. His patent on Formoterol tartrate showcases his dedication to improving drug formulations and underscores the importance of innovation in addressing medical needs. As he continues his work at Sepracor, Inc., the impact of his inventions will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…